Sfoglia per Autore
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS
2012-01-01 Martelli, Alma; Testai, Lara; Marino, Alice; Pugliesi, I; Taliani, Sabrina; Nesi, Giulia; Rapposelli, Simona; DA SETTIMO PASSETTI, Federico; Citi, Valentina; Breschi, MARIA CRISTINA; Calderone, Vincenzo
Natural organo-sulfur compounds inhibit RBL-2H3 mast cell degranulation
2013-01-01 Marino, Alice; Martelli, Alma; Testai, Lara; Citi, Valentina; Breschi, MARIA CRISTINA; Calderone, Vincenzo
Pharmacological evaluation of aryl-isothiocyanates as original H2S-donor derivatives: H2S-release and vascular effects
2013-01-01 Martelli, Alma; Testai, Lara; Citi, Valentina; Marino, Alice; Breschi, MARIA CRISTINA; Calderone, Vincenzo
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo
2013-01-01 Martelli, Alma; Testai, Lara; Citi, Valentina; Marino, Alice; Pugliesi, Isabella; Barresi, Elisabetta; Nesi, Giulia; Rapposelli, Simona; Taliani, Sabrina; DA SETTIMO PASSETTI, Federico; Breschi, MARIA CRISTINA; Calderone, Vincenzo
Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC
2014-01-01 DEL RE, Marzia; Landi, L; Tiseo, M; Camerini, A; Petrini, Iacopo; Inno, A; Citi, V; Salvini, J; Minuti, Gabriele; Vasile, E; Falcone, Alfredo; Gori, S; Amoroso, D; Ardizzoni, A; Cappuzzo, F; Danesi, Romano
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player?
2014-01-01 Martelli, Alma; Testai, Lara; Citi, Valentina; Marino, Alice; Francesca G., Bellagambi; Ghimenti, Silvia; Breschi, MARIA CRISTINA; Calderone, Vincenzo
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae?
2014-01-01 Citi, Valentina; Martelli, Alma; Testai, Lara; Marino, Alice; Breschi, MARIA CRISTINA; Calderone, Vincenzo
KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA
2015-01-01 DEL RE, Marzia; Tiseo, M.; D'Incecco, A.; Camerini, A.; Petrini, Iacopo; Lucchesi, M.; Inno, A.; Spada, D.; Bordi, P.; Vasile, E.; Citi, Valentina; Malpeli, G.; Testa, E.; Gori, S.; Falcone, Alfredo; Amoroso, D.; Chella, A.; Cappuzzo, F.; Ardizzoni, A.; Scarpa, A.; Danesi, Romano
DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: Pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer.
2015-01-01 Cremolini, Chiara; DEL RE, Marzia; Loupakis, Fotios; Marmorino, F.; Citi, Valentina; Palombi, M.; Bergamo, F.; Schirripa, Marta; Rossini, D.; Cortesi, E.; Tomasello, G.; Spadi, R.; Buonadonna, A.; Amoroso, D.; Vitello, S.; Di Donato, S.; Granetto, C.; D'Amico, M.; Falcone, Alfredo; Danesi, Romano
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions
2015-01-01 Testai, Lara; D'Antongiovanni, Vanessa; Piano, Ilaria; Martelli, Alma; Citi, Valentina; Duranti, Emiliano; Virdis, Agostino; Blandizzi, Corrado; Gargini, MARIA CLAUDIA; Breschi, MARIA CRISTINA; Calderone, Vincenzo
The novel H2S donor 4-carboxy-phenyl isothiocyanate inhibits mast cell degranulation and renin release by decreasing intracellular calcium
2016-01-01 Marino, Alice; Martelli, Alma; Citi, Valentina; Fu, M; Wang, R; Calderone, Vincenzo; Levi, R.
Should CYP2D6 be genotyped when treating with tamoxifen?
2016-01-01 DEL RE, Marzia; Rofi, Eleonora; Citi, Valentina; Fidilio, Leonardo; Danesi, Romano
Using hydrogen sulfide to design and develop drugs
2016-01-01 Calderone, Vincenzo; Martelli, Alma; Testai, Lara; Citi, Valentina; Breschi, MARIA CRISTINA
D -Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase
2016-01-01 Brancaleone, Vincenzo; Esposito, Iolanda; Gargiulo, Antonella; Vellecco, Valentina; Asimakopoulou, Antonia; Citi, Valentina; Calderone, Vincenzo; Gobbetti, Thomas; Perretti, Mauro; Papapetropoulos, Andreas; Bucci, Mariarosaria; Cirino, Giuseppe
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress
2016-01-01 Testai, Lara; Marino, Alice; Piano, Ilaria; Brancaleone, V; Tomita, K; Di Cesare Mannelli, L; Martelli, Alma; Citi, Valentina; Breschi, MARIA CRISTINA; Levi, R; Gargini, MARIA CLAUDIA; Bucci, M; Cirino, G; Ghelardini, C; Calderone, Vincenzo
Iminothioethers As A Novel Class Of H2s-Donor: Gasotransmitter Release And Vascular Effects
2016-01-01 Barresi, Elisabetta; Robello, Marco; Taliani, Sabrina; DA SETTIMO PASSETTI, Federico; Martelli, Alma; Testai, Lara; Citi, Valentina; Piragine, Eugenia; Rapposelli, Simona; Nesi, Giulia; Piano, Ilaria; Breschi, MARIA CRISTINA; Calderone, Vincenzo
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?
2016-01-01 DEL RE, Marzia; Citi, Valentina; Crucitta, Stefania; Rofi, Eleonora; Belcari, Francesca; Van Schaik, R. H.; Danesi, Romano
KRAS mutations as potential mechanism of crizotinib acquired resistance: a study on circulating tumor DNA
2016-01-01 DEL RE, Marzia; Bordi, Paola; Citi, Valentina; Crucitta, Stefania; Rofi, Eleonora; Petrini, Iacopo; Tiseo, Marcello; Danesi, Romano
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects
2017-01-01 Barresi, E.; Taliani, S.; Da Settimo, F.; Martelli, A.; Testai, L.; Citi, V.; Piragine, E.; Rapposelli, S.; Nesi, G.; Piano, I.; Gargini, M.; Breschi, M. C.; Calderone, V.
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer
2017-01-01 Cremolini, Chiara; Del Re, Marzia; Antoniotti, Carlotta; Lonardi, Sara; Bergamo, Francesca; Loupakis, Fotios; Borelli, Beatrice; Marmorino, Federica; Citi, Valentina; Cortesi, Enrico; Moretto, Roberto; Ronzoni, Monica; Tomasello, Gianluca; Zaniboni, Alberto; Racca, Patrizia; Buonadonna, Angela; Allegrini, Giacomo; Ricci, Vincenzo; Donato, Samantha Di; Zagonel, Vittorina; Boni, Luca; Falcone, Alfredo; Danesi, Romano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS | 1-gen-2012 | Martelli, Alma; Testai, Lara; Marino, Alice; Pugliesi, I; Taliani, Sabrina; Nesi, Giulia; Rapposelli, Simona; DA SETTIMO PASSETTI, Federico; Citi, Valentina; Breschi, MARIA CRISTINA; Calderone, Vincenzo | |
| Natural organo-sulfur compounds inhibit RBL-2H3 mast cell degranulation | 1-gen-2013 | Marino, Alice; Martelli, Alma; Testai, Lara; Citi, Valentina; Breschi, MARIA CRISTINA; Calderone, Vincenzo | |
| Pharmacological evaluation of aryl-isothiocyanates as original H2S-donor derivatives: H2S-release and vascular effects | 1-gen-2013 | Martelli, Alma; Testai, Lara; Citi, Valentina; Marino, Alice; Breschi, MARIA CRISTINA; Calderone, Vincenzo | |
| Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo | 1-gen-2013 | Martelli, Alma; Testai, Lara; Citi, Valentina; Marino, Alice; Pugliesi, Isabella; Barresi, Elisabetta; Nesi, Giulia; Rapposelli, Simona; Taliani, Sabrina; DA SETTIMO PASSETTI, Federico; Breschi, MARIA CRISTINA; Calderone, Vincenzo | |
| Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC | 1-gen-2014 | DEL RE, Marzia; Landi, L; Tiseo, M; Camerini, A; Petrini, Iacopo; Inno, A; Citi, V; Salvini, J; Minuti, Gabriele; Vasile, E; Falcone, Alfredo; Gori, S; Amoroso, D; Ardizzoni, A; Cappuzzo, F; Danesi, Romano | |
| Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? | 1-gen-2014 | Martelli, Alma; Testai, Lara; Citi, Valentina; Marino, Alice; Francesca G., Bellagambi; Ghimenti, Silvia; Breschi, MARIA CRISTINA; Calderone, Vincenzo | |
| Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? | 1-gen-2014 | Citi, Valentina; Martelli, Alma; Testai, Lara; Marino, Alice; Breschi, MARIA CRISTINA; Calderone, Vincenzo | |
| KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA | 1-gen-2015 | DEL RE, Marzia; Tiseo, M.; D'Incecco, A.; Camerini, A.; Petrini, Iacopo; Lucchesi, M.; Inno, A.; Spada, D.; Bordi, P.; Vasile, E.; Citi, Valentina; Malpeli, G.; Testa, E.; Gori, S.; Falcone, Alfredo; Amoroso, D.; Chella, A.; Cappuzzo, F.; Ardizzoni, A.; Scarpa, A.; Danesi, Romano | |
| DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: Pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer. | 1-gen-2015 | Cremolini, Chiara; DEL RE, Marzia; Loupakis, Fotios; Marmorino, F.; Citi, Valentina; Palombi, M.; Bergamo, F.; Schirripa, Marta; Rossini, D.; Cortesi, E.; Tomasello, G.; Spadi, R.; Buonadonna, A.; Amoroso, D.; Vitello, S.; Di Donato, S.; Granetto, C.; D'Amico, M.; Falcone, Alfredo; Danesi, Romano | |
| Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions | 1-gen-2015 | Testai, Lara; D'Antongiovanni, Vanessa; Piano, Ilaria; Martelli, Alma; Citi, Valentina; Duranti, Emiliano; Virdis, Agostino; Blandizzi, Corrado; Gargini, MARIA CLAUDIA; Breschi, MARIA CRISTINA; Calderone, Vincenzo | |
| The novel H2S donor 4-carboxy-phenyl isothiocyanate inhibits mast cell degranulation and renin release by decreasing intracellular calcium | 1-gen-2016 | Marino, Alice; Martelli, Alma; Citi, Valentina; Fu, M; Wang, R; Calderone, Vincenzo; Levi, R. | |
| Should CYP2D6 be genotyped when treating with tamoxifen? | 1-gen-2016 | DEL RE, Marzia; Rofi, Eleonora; Citi, Valentina; Fidilio, Leonardo; Danesi, Romano | |
| Using hydrogen sulfide to design and develop drugs | 1-gen-2016 | Calderone, Vincenzo; Martelli, Alma; Testai, Lara; Citi, Valentina; Breschi, MARIA CRISTINA | |
| D -Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase | 1-gen-2016 | Brancaleone, Vincenzo; Esposito, Iolanda; Gargiulo, Antonella; Vellecco, Valentina; Asimakopoulou, Antonia; Citi, Valentina; Calderone, Vincenzo; Gobbetti, Thomas; Perretti, Mauro; Papapetropoulos, Andreas; Bucci, Mariarosaria; Cirino, Giuseppe | |
| The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress | 1-gen-2016 | Testai, Lara; Marino, Alice; Piano, Ilaria; Brancaleone, V; Tomita, K; Di Cesare Mannelli, L; Martelli, Alma; Citi, Valentina; Breschi, MARIA CRISTINA; Levi, R; Gargini, MARIA CLAUDIA; Bucci, M; Cirino, G; Ghelardini, C; Calderone, Vincenzo | |
| Iminothioethers As A Novel Class Of H2s-Donor: Gasotransmitter Release And Vascular Effects | 1-gen-2016 | Barresi, Elisabetta; Robello, Marco; Taliani, Sabrina; DA SETTIMO PASSETTI, Federico; Martelli, Alma; Testai, Lara; Citi, Valentina; Piragine, Eugenia; Rapposelli, Simona; Nesi, Giulia; Piano, Ilaria; Breschi, MARIA CRISTINA; Calderone, Vincenzo | |
| Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? | 1-gen-2016 | DEL RE, Marzia; Citi, Valentina; Crucitta, Stefania; Rofi, Eleonora; Belcari, Francesca; Van Schaik, R. H.; Danesi, Romano | |
| KRAS mutations as potential mechanism of crizotinib acquired resistance: a study on circulating tumor DNA | 1-gen-2016 | DEL RE, Marzia; Bordi, Paola; Citi, Valentina; Crucitta, Stefania; Rofi, Eleonora; Petrini, Iacopo; Tiseo, Marcello; Danesi, Romano | |
| Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects | 1-gen-2017 | Barresi, E.; Taliani, S.; Da Settimo, F.; Martelli, A.; Testai, L.; Citi, V.; Piragine, E.; Rapposelli, S.; Nesi, G.; Piano, I.; Gargini, M.; Breschi, M. C.; Calderone, V. | |
| DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer | 1-gen-2017 | Cremolini, Chiara; Del Re, Marzia; Antoniotti, Carlotta; Lonardi, Sara; Bergamo, Francesca; Loupakis, Fotios; Borelli, Beatrice; Marmorino, Federica; Citi, Valentina; Cortesi, Enrico; Moretto, Roberto; Ronzoni, Monica; Tomasello, Gianluca; Zaniboni, Alberto; Racca, Patrizia; Buonadonna, Angela; Allegrini, Giacomo; Ricci, Vincenzo; Donato, Samantha Di; Zagonel, Vittorina; Boni, Luca; Falcone, Alfredo; Danesi, Romano |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile